IOmx Therapeutics AG | WebDisclosure

BRIEF

published on 12/19/2024 at 14:05, 2 days 16 hours ago

IOmx Therapeutics Advances IOMX-0675 with Clinical Trial Application

Cancer Treatment Clinical Trial Application IOmx Therapeutics IOMX-0675 Immunosuppressive Receptors
BRIEF

published on 12/19/2024 at 14:05, 2 days 16 hours ago

IOmx Therapeutics fait progresser IOMX-0675 avec une application d'essai clinique

Traitement Du Cancer Thérapeutique IOmx IOMX-0675 Demande D'essai Clinique Récepteurs Immunosuppresseurs
PRESS RELEASE

published on 12/19/2024 at 14:00, 2 days 16 hours ago

iOmx Therapeutics submits Clinical Trial Application for IOMX-0675
iOmx Therapeutics submits Clinical Trial Application for IOMX-0675, a dual-targeting antibody demonstrating strong anti-tumor potential by reprogramming myeloid cells and restoring cytotoxic T cell function

Clinical Trial Application IOmx Therapeutics IOMX-0675 Immunosuppressive Receptors Anti-tumor Potential
BRIEF

published on 08/22/2024 at 10:05, 3 months 30 days ago

IOmx Therapeutics Initiates Phase Ib with OMX-0407

Cancer Therapy Clinical Trial IOmx Therapeutics OMX-0407 Phase Ib
BRIEF

published on 08/22/2024 at 10:05, 3 months 30 days ago

IOmx Therapeutics lance la phase Ib avec OMX-0407

Essai Clinique Thérapie Contre Le Cancer OMX-0407 Phase Ib Thérapeutique IOmx
PRESS RELEASE

published on 08/22/2024 at 10:00, 3 months 30 days ago

iOmx Therapeutics Initiates Phase Ib with OMX-0407
iOmx Therapeutics initiates Phase Ib clinical trial with OMX-0407, showing favorable safety profile and anti-tumor activity in solid tumors. Expansion phase opens in kidney cancer and angiosarcoma

Solid Tumors Clinical Trial IOmx Therapeutics OMX-0407 Phase Ib
BRIEF

published on 06/27/2024 at 10:05, 5 months 24 days ago

IOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer

Chief Financial Officer Biopharmaceutical Leadership IOmx Therapeutics Florian Schmid
BRIEF

published on 06/27/2024 at 10:05, 5 months 24 days ago

IOmx Therapeutics nomme Florian Schmid au poste de directeur financier

Biopharmaceutique Direction Directeur Financier Florian Schmid IOmx Thérapeutique
PRESS RELEASE

published on 06/27/2024 at 10:00, 5 months 24 days ago

iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer
iOmx Therapeutics appoints Florian Schmid as new Chief Financial Officer, succeeding Marcus Irsfeld. Schmid brings 20+ years of financial leadership experience in biopharma. Company aims to advance immuno-oncology drug candidates

Chief Financial Officer Biopharmaceutical Immuno-oncology IOmx Therapeutics Florian Schmid
PRESS RELEASE

published on 11/01/2023 at 10:00, 1 year 1 month ago

iOmx Therapeutics attends upcoming scientific and industry conferences

Published on 12/21/2024 at 01:30, 1 day 5 hours ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 5 hours ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 6 hours ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 1 day 6 hours ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 1 day 7 hours ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 1 day 5 hours ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 1 day 6 hours ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day 11 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 11 hours ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 18 hours 32 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 18 hours 32 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 12 hours ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News